ClinTec International launches master’s program

Friday, June 21, 2013 10:22 AM

Global CRO ClinTec International, which has a presence in over 40 countries worldwide, has formally launched its MSc in International Clinical Research and Technology in collaboration with Edinburgh Napier University.

The event marked the arrival of the first of its kind of be launched by a U.K.-based CRO. Students from 13 different countries–Austria, Czech Republic, France, India, Lebanon, Lithuania, Philippines, Russia, Slocenia, South Africa, Sweden, and the U.K.–have enrolled.

"The launch of this master's degree shows the committment we have toward nurturing the talent of the future," said Dr. Rabinder Buttar, Clintec founder and CEO. "The clinical research market is constantly evolving with new markets and trends emerging year after year. It is my hope that this course will give candidates the tools and knowledge they require in order to be successful after graduation."

The degree has been developed in collaboration with Edinburgh Napier University, which provides both undergraduate and post-graduate qualifications in clinical research. Taught by professionals from both the university and ClinTec's global team, the Master's course is designed for clinical research professionals and will be taught online on a part-time basis through an interactive learning platform or in person at ENU campuses.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs